{
  "company": {
    "name": "EdiGene",
    "website": "https://edigene.com/",
    "record": "https://startuphistory.org/c/edigene.com"
  },
  "status": null,
  "history_since": "2017-03-23T00:10:10.000Z",
  "baseline": {
    "snapshot_id": "737bfe413deeb75311099c8ec4138f106531e9e54dc62b2a0dbfb31cdb1cdb14",
    "observed_at": "2019-01-03T00:09:05.000Z",
    "headline": null,
    "description": "EdiGene is a biotechnology company with a mission to translate the cutting-edge genome editing technologies into novel therapeutics for genetic diseases and cancer, and into creative solutions to adva",
    "evidence": "https://web.archive.org/web/20190103000905/http://edigene.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T13:44:45.998Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2023-07-06T11:43:35.000Z",
      "variants": [
        {
          "headline": "EdiGene | Genome Editing for a Better Life",
          "subhead": "EdiGene is a biotechnology company with a mission to translate the cutting-edge genome editing technologies into novel therapeutics for genetic diseases and cancer, and into creative solutions to adva",
          "observed_at": "2021-01-17T21:35:31.000Z",
          "evidence": "https://web.archive.org/web/20210117213531/https://www.edigene.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "EdiGene | Genome Editing for a Better Life",
          "subhead": "EdiGene is a biotechnology company with a mission to translate the cutting-edge genome editing technologies into novel therapeutics for genetic diseases and cancer, and into creative solutions to adva",
          "observed_at": "2022-07-02T20:07:46.000Z",
          "evidence": "https://web.archive.org/web/20220702200746/https://www.edigene.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "EdiGene | Genome Editing for a Better Life",
          "subhead": "EdiGene is a biotechnology company with a mission to translate the cutting-edge genome editing technologies into novel therapeutics for genetic diseases and cancer, and into creative solutions to adva",
          "observed_at": "2023-07-06T11:43:35.000Z",
          "evidence": "https://web.archive.org/web/20230706114335/https://www.edigene.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "EdiGene | Genome Editing for a Better Life",
      "subhead": "EdiGene is a biotechnology company with a mission to translate the cutting-edge genome editing technologies into novel therapeutics for genetic diseases and cancer, and into creative solutions to adva",
      "from": "2021-01-17T21:35:31.000Z",
      "to": "2023-07-06T11:43:35.000Z",
      "captures": 3,
      "evidence": "https://web.archive.org/web/20230706114335/https://www.edigene.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2021-01-17T21:35:31.000Z",
          "to": "2023-07-06T11:43:35.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-05T13:44:45.998Z",
      "variants": [
        {
          "headline": "博雅辑因 | 辑生命之密码 解世间之顽疾",
          "subhead": "EdiGene是一家生物技术公司，其使命是将前沿的基因组编辑技术转化为治疗遗传病和癌症的新疗法，并将其转化为创新的解决方案，以推进药物发现。我们利用我们的专有平台来开发针对一系列疾病的基因编辑疗法，并进行高通量的基因组筛选，以便能够在生物学环境中剖析功能性大数据。",
          "observed_at": "2024-07-21T22:15:17.000Z",
          "evidence": "https://web.archive.org/web/20240721221517/https://www.edigene.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "博雅辑因 | 辑生命之密码 解世间之顽疾",
          "subhead": "EdiGene是一家生物技术公司，其使命是将前沿的基因组编辑技术转化为治疗遗传病和癌症的新疗法，并将其转化为创新的解决方案，以推进药物发现。我们利用我们的专有平台来开发针对一系列疾病的基因编辑疗法，并进行高通量的基因组筛选，以便能够在生物学环境中剖析功能性大数据。",
          "observed_at": "2025-07-10T07:40:36.000Z",
          "evidence": "https://web.archive.org/web/20250710074036/https://edigene.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "博雅辑因 | 辑生命之密码 解世间之顽疾",
          "subhead": "EdiGene是一家生物技术公司，其使命是将前沿的基因组编辑技术转化为治疗遗传病和癌症的新疗法，并将其转化为创新的解决方案，以推进药物发现。我们利用我们的专有平台来开发针对一系列疾病的基因编辑疗法，并进行高通量的基因组筛选，以便能够在生物学环境中剖析功能性大数据。",
          "observed_at": "2025-08-03T02:30:34.000Z",
          "evidence": "https://web.archive.org/web/20250803023034/https://edigene.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "博雅辑因 | 辑生命之密码 解世间之顽疾",
          "subhead": "EdiGene是一家生物技术公司，其使命是将前沿的基因组编辑技术转化为治疗遗传病和癌症的新疗法，并将其转化为创新的解决方案，以推进药物发现。我们利用我们的专有平台来开发针对一系列疾病的基因编辑疗法，并进行高通量的基因组筛选，以便能够在生物学环境中剖析功能性大数据。",
          "observed_at": "2026-07-12T02:52:34.000Z",
          "evidence": "https://web.archive.org/web/20260712025234/https://edigene.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "博雅辑因 | 辑生命之密码 解世间之顽疾",
          "subhead": "EdiGene是一家生物技术公司，其使命是将前沿的基因组编辑技术转化为治疗遗传病和癌症的新疗法，并将其转化为创新的解决方案，以推进药物发现。我们利用我们的专有平台来开发针对一系列疾病的基因编辑疗法，并进行高通量的基因组筛选，以便能够在生物学环境中剖析功能性大数据。",
          "observed_at": "2026-07-15T04:05:38.000Z",
          "evidence": "https://web.archive.org/web/20260715040538/https://www.edigene.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "博雅辑因 | 辑生命之密码 解世间之顽疾",
          "subhead": "EdiGene是一家生物技术公司，其使命是将前沿的基因组编辑技术转化为治疗遗传病和癌症的新疗法，并将其转化为创新的解决方案，以推进药物发现。我们利用我们的专有平台来开发针对一系列疾病的基因编辑疗法，并进行高通量的基因组筛选，以便能够在生物学环境中剖析功能性大数据。",
          "observed_at": "2026-10-03T20:13:55.000Z",
          "evidence": "https://web.archive.org/web/20261003201355/https://www.edigene.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "博雅辑因 | 辑生命之密码 解世间之顽疾",
          "subhead": "EdiGene是一家生物技术公司，其使命是将前沿的基因组编辑技术转化为治疗遗传病和癌症的新疗法，并将其转化为创新的解决方案，以推进药物发现。我们利用我们的专有平台来开发针对一系列疾病的基因编辑疗法，并进行高通量的基因组筛选，以便能够在生物学环境中剖析功能性大数据。",
          "observed_at": "2026-11-05T13:44:45.998Z",
          "evidence": "https://edigene.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "博雅辑因 | 辑生命之密码 解世间之顽疾",
      "subhead": "EdiGene是一家生物技术公司，其使命是将前沿的基因组编辑技术转化为治疗遗传病和癌症的新疗法，并将其转化为创新的解决方案，以推进药物发现。我们利用我们的专有平台来开发针对一系列疾病的基因编辑疗法，并进行高通量的基因组筛选，以便能够在生物学环境中剖析功能性大数据。",
      "from": "2024-07-21T22:15:17.000Z",
      "to": "2026-11-05T13:44:45.998Z",
      "captures": 7,
      "evidence": "https://edigene.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2024-07-21T22:15:17.000Z",
          "to": "2026-11-05T13:44:45.998Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-158565cc10f015435a042d6ed4446e35164ef15f4aa2d38b22a15b0119effb3e:003edefc10c5de8a2393c3e6debf302f4dd92eca29f31f3452986814f011ce39:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20170323001010/http://www.edigene.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2017-03-23T00:10:10.000Z",
        "to": "2018-01-04T09:00:50.000Z"
      },
      "evidence": "https://web.archive.org/web/20180104090050/http://edigene.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “EdiGene” company record, https://startuphistory.org/c/edigene.com"
}